title: Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery.
abstract: BACKGROUND
  The number of gastric restrictive bariatric operations is increasing each year, but about one-fifth of patients will become disappointed due to unsatisfactory weight reduction or annoying complications. We questioned whether weight reduction by taking high doses of fluoxetine improves lifestyle before surgery.
  
  
  METHODS
  84 severely obese subjects were referred by one bariatric surgeon for medical weight reduction and dietary counseling, before bariatric surgery. Subjects were voluntarily treated with fluoxetine, 60 mg per day, and followed-up at 1, 3, 6 and 12 months. Surgery was scheduled between 6 to 12 months after subjects started to take fluoxetine. Endpoints of this study were body weight reductions, the number of individuals who decided for themselves to postpone surgery for at least 6 months, and side-effects of fluoxetine therapy.
  
  
  RESULTS
  84 severely obese subjects consisting of 28 men (group 1) and 41 women (group 2) consented to take fluoxetine for its anorectic effects, whereas 12 men and 3 women who did not want to take fluoxetine served as the control group (group 3). Weight in these 3 groups at baseline was 149+/-26, 124+/-17, and 132+/-23 (controls) (P<0.05) with BMI 46+/-3, 44+/-3, and 45+/-2 (controls) kg/m(2) (NS). Maximum weight reduction before surgery in male and female fluoxetine users occurred at 3 and 6 months, respectively. At 6 months, men had achieved a weight reduction (kg) of -8.3 (95% CI: -9.3 to -5.9), women of -13.3 (95% CI: -16.3 to -8.8), sex difference P<0.001, and controls of -1.6 (95% CI: -3.8 to -2.5) kg, group difference P<0.0001. Only 2 men stopped fluoxetine because of annoying sexual side-effects. At 6 months, 25 fluoxetine users (29.7%) and none of the controls consented to postpone the time of surgery for at least another 6 months.
  
  
  CONCLUSIONS
  Fluoxetine is effective to reduce weight in severely obese men and women who originally had requested to undergo bariatric surgery. One-third of subjects who consented to take fluoxetine as an anorectic drug agreed to delay surgery for at least 6 months later than scheduled.
authors.affiliation: Department of Gynecology and Obstetrics University Hospital Groningen, The Netherlands.
authors.forename: Jacqueline G
authors.initials: JG
authors.lastname: Dolfing
authors.forename: Bruce H R
authors.initials: BH
authors.lastname: Wolffenbuttel
authors.forename: Nienke M
authors.initials: NM
authors.lastname: ten Hoor-Aukema
authors.forename: Dave H
authors.initials: DH
authors.lastname: Schweitzer
mesh_terms: D000328:Adult; D001067:Appetite Depressants / Q000494:pharmacology / Q000627:therapeutic use*; D050110:Bariatric Surgery; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology / Q000627:therapeutic use*; D015438:Health Behavior; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000188:drug therapy* / Q000601:surgery; D013997:Time Factors; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D001067:Appetite Depressants; D005473:Fluoxetine